Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza

Lentiviral-mediated expression of monoclonal antibodies in the lung to protect against influenza

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Du, Y, Munday, RJ, Tan, TK, Rijal, P, Townsend, AR, Hyde, SC, Gill, DR
Μορφή:	Conference item
Γλώσσα:	English
Έκδοση:	Cell Press 2020

Παρόμοια τεκμήρια

Lung-targeting lentiviral vector for passive immunisation against influenza
ανά: Tan, TK, κ.ά.
Έκδοση: (2020)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
ανά: Tan, T, κ.ά.
Έκδοση: (2018)

431. Lung antibody factory for passive immunisation against influenza
ανά: Tan, T, κ.ά.
Έκδοση: (2016)

Investigating pseudotyped lentiviral vectors for gene delivery to the lung
ανά: Munday, RJ
Έκδοση: (2021)

Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
ανά: Zuleika Michelini, κ.ά.
Έκδοση: (2020-12-01)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
ανά: Munday, R, κ.ά.
Έκδοση: (2019)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
ανά: Munday, R, κ.ά.
Έκδοση: (2018)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
ανά: Munday, RJ, κ.ά.
Έκδοση: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
ανά: Munday, RJ, κ.ά.
Έκδοση: (2022)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
ανά: Munday, RJ, κ.ά.
Έκδοση: (2022)

Broadly inhibiting antineuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
ανά: Rijal, P, κ.ά.
Έκδοση: (2020)

Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies
ανά: Antepowicz, A, κ.ά.
Έκδοση: (2016)

A study of human monoclonal antibodies to influenza and ebola viruses
ανά: Rijal, P
Έκδοση: (2016)

Rapid determination of rSIV.F/HN lentiviral vector titre
ανά: Conway, CC, κ.ά.
Έκδοση: (2020)

A direct contact pig influenza challenge model for assessing protective efficacy of monoclonal antibodies
ανά: Adam McNee, κ.ά.
Έκδοση: (2023-10-01)

Use of pseudotyped, replication deficient influenza to facilitate testing of gene delivery strategies for treatment of highly infectious diseases
ανά: Tan, T, κ.ά.
Έκδοση: (2018)

Correction: Protective porcine influenza virus-specific monoclonal antibodies recognize similar haemagglutinin epitopes as humans
ανά: Barbara Holzer, κ.ά.
Έκδοση: (2021-08-01)

Broadly inhibiting anti-neuraminidase monoclonal antibodies induced by trivalent influenza vaccine and H7N9 infection in humans
ανά: Rijal, P, κ.ά.
Έκδοση: (2019)

Intranasal lentiviral vector-mediated antibody delivery confers reduction of SARS-CoV-2 infection in elderly and immunocompromised mice
ανά: Du, Y, κ.ά.
Έκδοση: (2022)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
ανά: Antepowicz, A, κ.ά.
Έκδοση: (2021)

Enhanced lentiviral production through rational design of mammalian host cells
ανά: Hyde, S, κ.ά.
Έκδοση: (2016)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
ανά: Gelinas, J, κ.ά.
Έκδοση: (2013)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
ανά: Agata Antepowicz, κ.ά.
Έκδοση: (2021-08-01)

Passive immunization with influenza haemagglutinin specific monoclonal antibodies
ανά: Rajeev Rudraraju, κ.ά.
Έκδοση: (2018-11-01)

Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
ανά: Nada Abbadi, κ.ά.
Έκδοση: (2023-01-01)

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins.
ανά: Taia T Wang, κ.ά.
Έκδοση: (2010-02-01)

Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
ανά: Fei-Fei Xiong, κ.ά.
Έκδοση: (2020-01-01)

Protective monoclonal antibodies to diphtheria toxin
ανά: Maria das Graças M. Danelli, κ.ά.
Έκδοση: (1991-06-01)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
ανά: Gélinas, J, κ.ά.
Έκδοση: (2017)

Mucosal immunization with integrase-defective lentiviral vectors protects against influenza virus challenge in mice.
ανά: Judith M Fontana, κ.ά.
Έκδοση: (2014-01-01)

Human monoclonal antibodies broadly neutralizing against influenza B virus.
ανά: Mayo Yasugi, κ.ά.
Έκδοση: (2013-02-01)

Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?
ανά: Cassandra M. Berry
Έκδοση: (2018-03-01)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
ανά: Shirin Strohmeier, κ.ά.
Έκδοση: (2022-07-01)

Hemagglutination Inhibition (HI) Assay of Influenza Viruses with Monoclonal Antibodies
ανά: Ying Wu, κ.ά.
Έκδοση: (2016-06-01)

Micro Neutralization (MN) Assay of Influenza Viruses with Monoclonal Antibodies
ανά: Ying Wu, κ.ά.
Έκδοση: (2016-06-01)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
ανά: Rosie J. Munday, κ.ά.
Έκδοση: (2022-09-01)

Human monoclonal antibodies from convalescent H7N9 patients in China and Taiwan
ανά: Rijal, P, κ.ά.
Έκδοση: (2014)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
ανά: Ashworth, R, κ.ά.
Έκδοση: (2018)

Development of recombinant Adeno-Associated Viral vector (rAAV) for passive immunisation against ebola
ανά: Tan, T, κ.ά.
Έκδοση: (2017)

A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration
ανά: Anna L. Beukenhorst, κ.ά.
Έκδοση: (2024-02-01)